The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Practice
PreviousPrevious
Volume 360:1639-1645 April 16, 2009 Number 16
NextNext

Molar Pregnancy
Ross S. Berkowitz, M.D., and Donald P. Goldstein, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Audio Icon Full Text Audio
-PowerPoint Slide Set
-CME Exam
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A healthy 37-year-old woman presents at 10 weeks of pregnancy with vaginal bleeding. Physical examination shows that the uterine size is appropriate for gestational age. The level of serum human chorionic gonadotropin (hCG) is 22,000 mIU per milliliter. Ultrasonography does not show an identifiable fetal heartbeat. After receiving a clinical diagnosis of missed abortion, the patient undergoes evacuation of the uterus; pathological . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Diagnosis

            Ultrasonographic Examination

            Measurement of hCG

            Challenges of Pathological Diagnosis

Management

Persistent Neoplasia after a Molar Pregnancy

Monitoring of hCG after Evacuation of the Mole

Subsequent Pregnancy

Areas of Uncertainty

Guidelines

Conclusions and Recommendations


Source Information

From the New England Trophoblastic Disease Center, Trophoblastic Tumor Registry; the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital; the Dana–Farber Cancer Institute; and Harvard Medical School — all in Boston.

An audio version of this article is available at NEJM.org.

Address reprint requests to Dr. Berkowitz at the Division of Gynecologic Oncology, Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115, or at rberkowitz@partners.org.




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.